Abstract
Objective
To report the clinical characteristics of pulmonary artery involvement (PAI) in patients with Behçet’s syndrome (BS) and to define the predictors of relapses.
Methods
We performed retrospective analysis of BS patients with PAI who fulfilled international study group criteria. Among 460 patients with vascular Behçet’s syndrome (VBS), 66 were diagnosed with PAI. For final analyses, 61 patients with PAI were included who had at least 2 follow-up visits (72.1% male, mean age at BS diagnosis 29.34 ± 10.1 years). The patient data were recorded. Relapse was defined as the reoccurrence of vascular event in any vascular structure. Factors associated with relapse were assessed by logistic regression analysis.
Results
There were no differences considering demographic and clinical features of the patients with and without PAI in the VBS group, except that intracardiac thrombosis was more common in the patients with PAI (19.7% vs 0.3%). Among 61 patients, 50 (82.0%) had isolated pulmonary artery thrombosis (PAT), whereas 11 (18.0%) had pulmonary artery aneurysm with or without PAT. Twenty-four (39.3%) patients experienced vascular relapse during median follow-up of 65.9 (Q1-Q3: 20.1–109.0) months. To define the factors associated with relapses, patients with isolated PAT were analysed. On multivariable logistic regression analysis, older age at BS diagnosis and anticoagulation usage seemed to be protective (OR: 0.92, 95% CI 0.86–1.02, OR: 0.34, 95% CI 0.09–1.33, respectively).
Conclusion
Our results indicate a higher frequency of intracardiac thrombosis in BS patients with PAI and possible efficacy of anticoagulation usage in preventing relapses.
Key Points • This study shows that intracardiac and intracranial thromboses are seen more frequently in patients with PAI and the prevalence of pulmonary artery thrombosis has been increasing in the case of PAI. Furthermore, our report indicates that anticoagulation might be effective in preventing further vascular relapses. |
Similar content being viewed by others
References
Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a contemporary view. Nat Rev Rheumatol 14(2):119. https://doi.org/10.1038/nrrheum.2018.3
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82(1):60–76. https://doi.org/10.1097/00005792-200301000-00006
Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H (2014) Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53(11):2018–2022. https://doi.org/10.1093/rheumatology/keu233
Seyahi E, Yazici H (2015) Behçet’s syndrome: pulmonary vascular disease. Curr Opin Rheumatol 27(1):18–23. https://doi.org/10.1097/bor.0000000000000131
Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, Yurdakul S, Tuzun H, Oz B, Yazici H (2012) Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 91(1):35–48. https://doi.org/10.1097/MD.0b013e318242ff37
Raz I, Okon E, Chajek-Shaul T (1989) Pulmonary manifestations in Behçet's syndrome. Chest 95(3):585–589. https://doi.org/10.1378/chest.95.3.585
Edrees A, Naguib S, El Menyawi M, Ismail I, Nagah H (2017) Pulmonary manifestations in a group of patients with Behcet's disease. Int J Rheum Dis 20(2):269–275. https://doi.org/10.1111/1756-185x.12626
Hamuryudan V, Yurdakul S, Moral F, Numan F, Tüzün H, Tüzüner N, Mat C, Tüzün Y, Ozyazgan Y, Yazïci H (1994) Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. Br J Rheumatol 33(1):48–51. https://doi.org/10.1093/rheumatology/33.1.48
Hamuryudan V, Er T, Seyahi E, Akman C, Tüzün H, Fresko I, Yurdakul S, Numan F, Yazici H (2004) Pulmonary artery aneurysms in Behçet syndrome. Am J Med 117(11):867–870. https://doi.org/10.1016/j.amjmed.2004.05.027
Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M, Cacoub P (2010) Mortality in Behçet's disease. Arthritis Rheum 62(9):2806–2812. https://doi.org/10.1002/art.27568
Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in behcet disease: a cumulative analysis. Chest 127(6):2243–2253. https://doi.org/10.1378/chest.127.6.2243
Ozguler Y, Dincses E, Bakan S, Hatemi G, Melikoglu M, Ugurlu S, Yurdakul S, Yazici H, Seyahi E (2018) SAT0525 An update on pulmonary artery involvement in behcet’s syndrome: more pulmonary artery thrombotic disease and a better outcome. Ann Rheum Dis 77(Suppl 2):1118. https://doi.org/10.1136/annrheumdis-2018-eular.6675
Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H (2018) 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis 77(6):808–818. https://doi.org/10.1136/annrheumdis-2018-213225
Tuzun H, Seyahi E, Guzelant G, Oz B, Batur S, Demirhan O, Hamuryudan V (2018) Surgical Treatment of Pulmonary Complications in Behçet's Syndrome. Semin Thorac Cardiovasc Surg 30(3):369–378. https://doi.org/10.1053/j.semtcvs.2018.07.008
Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease (1990). Lancet 335 (8697):1078-1080
Saadoun D, Asli B, Wechsler B, Houman H, Geri G, Desseaux K, Piette JC, Huong du LT, Amoura Z, Salem TB, Cluzel P, Koskas F, Resche-Rigon M, Cacoub P (2012) Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine (Baltimore) 91 (1):18-24. doi:https://doi.org/10.1097/MD.0b013e3182428126
Wu X, Li G, Huang X, Wang L, Liu W, Zhao Y, Zheng W (2014) Behçet's disease complicated with thrombosis: a report of 93 Chinese cases. Medicine (Baltimore) 93(28):e263. https://doi.org/10.1097/md.0000000000000263
Kechida M, Salah S, Kahloun R, Klii R, Hammami S, Khochtali I (2018) Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Advances in Rheumatology 58:32
Chen Y, Cai JF, Lin CH, Guan JL (2019) Demography of vascular Behcet's disease with different gender and age: an investigation with 166 Chinese patients. Orphanet J Rare Dis 14(1):88. https://doi.org/10.1186/s13023-019-1061-1
Tunaci M, Ozkorkmaz B, Tunaci A, Gül A, Engin G, Acunaş B (1999) CT findings of pulmonary artery aneurysms during treatment for Behçet's disease. AJR Am J Roentgenol 172(3):729–733. https://doi.org/10.2214/ajr.172.3.10063870
Uzun O, Erkan L, Akpolat I, Findik S, Atici AG, Akpolat T (2008) Pulmonary involvement in Behçet's disease. Respiration 75(3):310–321. https://doi.org/10.1159/000101954
Zhang X, Dai H, Ma Z, Yang Y, Liu Y (2015) Pulmonary involvement in patients with Behçet's disease: report of 15 cases. Clin Respir J 9(4):414–422. https://doi.org/10.1111/crj.12153
Seyahi E, Karaaslan H, Ugurlu S, Yazici H (2013) Fever in Behçet's syndrome. Clin Exp Rheumatol 31(3 Suppl 77):64–67
Zhou J, Shi J, Liu J, Sun L, Li L, Li C, Wu X, Wang Y, Tian X, Zeng X, Liu Y, Zheng W, Zhao Y (2019) The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease. J Immunol Res 2019:9198506–9198508. https://doi.org/10.1155/2019/9198506
Emmungil H, Yaşar Bilge N, Küçükşahin O, Kılıç L, Okutucu S, Gücenmez S, Kalyoncu U, Kaşifoğlu T, Turgay M, Aksu K (2014) A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients. Clin Exp Rheumatol 32(4 Suppl 84):S87–S92
Gurcan M, Esatoglu SN, Hamuryudan V, Saygin D, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Yurdakul S, Yazici H, Hatemi G (2020) Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide. Rheumatology (Oxford) 59(9):2264–2271. https://doi.org/10.1093/rheumatology/kez598
Hamuryudan V, Seyahi E, Ugurlu S, Melikoglu M, Hatemi G, Ozguler Y, Akman C, Tuzun H, Yurdakul S, Yazici H (2015) Pulmonary artery involvement in Behçet′s syndrome: Effects of anti-Tnf treatment. Semin Arthritis Rheum 45(3):369–373. https://doi.org/10.1016/j.semarthrit.2015.06.008
Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, Koskas F, Desseaux K, Cacoub P, Saadoun D (2012) Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. Arthritis Rheum 64(8):2753–2760. https://doi.org/10.1002/art.34450
Alibaz-Oner F, Karadeniz A, Ylmaz S, Balkarl A, Kimyon G, Yazc A, Çnar M, Ylmaz S, Yldz F, Bilge ŞY, Bilgin E, Coskun BN, Omma A, Çetin GY, Çağatay Y, Karaaslan Y, Sayarlioğlu M, Pehlivan Y, Kalyoncu U, Karadağ Ö, Kaşifoğlu T, Erken E, Pay S, Çefle A, Kisacik B, Onat AM, Çobankara V, Direskeneli H (2015) Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine (Baltimore) 94(6):e494. https://doi.org/10.1097/md.0000000000000494
Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS (2008) Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 27(2):201–205. https://doi.org/10.1007/s10067-007-0685-z
Seyahi E, Cakmak OS, Tutar B, Arslan C, Dikici AS, Sut N, Kantarci F, Tuzun H, Melikoglu M, Yazici H (2015) Clinical and Ultrasonographic Evaluation of Lower-extremity Vein Thrombosis in Behcet Syndrome: An Observational Study. Medicine (Baltimore) 94(44):e1899. https://doi.org/10.1097/md.0000000000001899
Ozguler Y, Hatemi G, Cetinkaya F, Tascilar K, Hamuryudan V, Ugurlu S, Seyahi E, Yazici H, Melikoglu M (2020) Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome. Rheumatology (Oxford) 59(4):799–806. https://doi.org/10.1093/rheumatology/kez352
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Eroglu, D.S., Torgutalp, M., Baysal, S. et al. Clinical characteristics of pulmonary artery involvement in patients with Behçet’s syndrome: single-centre experience of 61 patients. Clin Rheumatol 40, 4127–4134 (2021). https://doi.org/10.1007/s10067-021-05748-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-05748-x